TRexBio
TRex Bio
- Employees
- 11–50
- Business Model
- B2B
- Website
- trex.bio
- Total Funding
- $219.0M
- Last Round
- $50.0M Extension RoundJan 2026
- Rounds
- 4
About
Develops purpose-built biologics targeting immune balance in autoimmune and inflammatory diseases through tissue biology.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jan 2026
Nov 2024
Mar 2022
Jun 2021
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...